A Randomized Trial of Weekly Parenteral Methotrexate Versus `Pulsed' Dactinomycin as Primary Manangement for Low Risk Gestational Trophoblastic Neoplasia.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Dactinomycin; Methotrexate
- Indications Trophoblastic tumour
- Focus Therapeutic Use
- 15 May 2018 Biomarkers information updated
- 18 Jul 2012 Actual end date changed from Mar 2010 to Jul 2010 as reported by ClinicalTrials.gov.
- 09 Jan 2012 Actual end date changed from Feb 2003 to Mar 2010 as reported by ClinicalTrials.gov.